Loading
The GLOBOCAN-based world count for 2012: about 14.1 million new cancer cases, with more than half of cases and almost two thirds of deaths occurring in less developed regions, and lung cancer leading in men while breast cancer led in women.
Torre, Bray, Siegel and colleagues summarised the GLOBOCAN 2012 estimates for the American Cancer Society. They reported about 14.1 million new cases and 8.2 million deaths in 2012, with 57% of cases and 65% of deaths in less developed regions. Lung cancer was the leading cancer in men for both incidence and mortality; breast cancer led in women. The paper highlighted the rising share of the burden in transitioning countries and the potential of prevention, early detection and treatment to reduce it.
One of the most cited descriptions of the global cancer burden of the 2010s, it framed the shift of cancer towards lower-income countries that later GLOBOCAN releases have confirmed.
Anyone using GLOBOCAN numbers should know how they are produced; this paper explains the method hierarchy and why figures for countries without good registries carry wide uncertainty.
For years the most cited paper in oncology, it fixed the picture of cancer as a growing problem of developing countries and is the baseline against which the 2012, 2018, 2020 and 2022 GLOBOCAN releases show the burden rising.
Shares Jemal 2011: Global cancer statistics (GLOBOCAN 2008), Freddie Bray, Incidence versus prevalence, Mortality.
Shares Freddie Bray, Bray 2018: GLOBOCAN 2018, worldwide incidence and mortality for 36 cancers, Incidence versus prevalence, Mortality.
Shares Bray 2018: GLOBOCAN 2018, worldwide incidence and mortality for 36 cancers, Incidence versus prevalence, Mortality, International Agency for Research on Cancer (IARC / WHO).
Shares Freddie Bray, Bray 2018: GLOBOCAN 2018, worldwide incidence and mortality for 36 cancers, International Agency for Research on Cancer (IARC / WHO), HR-positive / HER2-negative breast cancer.
Shares Bray 2018: GLOBOCAN 2018, worldwide incidence and mortality for 36 cancers, Incidence versus prevalence, Mortality, Non-small-cell lung cancer.
Shares Bray 2018: GLOBOCAN 2018, worldwide incidence and mortality for 36 cancers, Incidence versus prevalence, Mortality, Non-small-cell lung cancer.
Shares Bray 2018: GLOBOCAN 2018, worldwide incidence and mortality for 36 cancers, Mortality, HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer.
Shares Incidence versus prevalence, Mortality, International Agency for Research on Cancer (IARC / WHO).